“Phosphoinositide 3-Kinase-Based Dual-Target Inhibitors for Cancer Therapy: Rational Design, Structure-Activity Relationships and Biological Evaluation: Review Paper”. ADMET and DMPK, vol. 14, 3693, Nov. 2026, https://doi.org/10.5599/admet.3693.